Our proprietary network, MASH Clinical, is a global network of clinicians and investigators that includes endocrinologists, gastroenterologists, diabetologists, and general internists with connections to hospitals worldwide. They have vast experience as a group and are devoted to improving MASH (NASH) trials.
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis
A paper published in Clinical Rheumatology from the research group of our Scientific Officer Manuel Castro Cabezas and Chief Scientific Officer Rick Grobbee indicates that patients with rheumatoid arthritis with high liver fibrosis scores are like...